UBS O'Connor’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
KIM
FTCM
PMAM
AIMCA
AA
HIM
WCMNY
MI
LP
UBS O'Connor's GPAT Position: Q4 2025 in Review
UBS O'Connor reduced its GP-Act III Acquisition Corp (GPAT) stake by 29% in Q4 2025, selling an estimated $1.07M and leaving 250,000 shares worth $2.67M. The position accounts for 0.08% of the portfolio, ranked #81.
UBS O'Connor first reported a position in GPAT in Q2 2025 and has held it in 3 quarters since. The position peaked at $3.71M in Q3 2025. 52 funds tracked by Wall St. Rank hold GPAT as of Q4 2025.
- UBS O'Connor held 250,000 shares of GP-Act III Acquisition Corp worth $2.67M as of Q4 2025.
- UBS O'Connor sold 100,000 GP-Act III Acquisition Corp shares in Q4 2025, an estimated $1.07M.
- GP-Act III Acquisition Corp made up 0.08% of UBS O'Connor's portfolio in Q4 2025, its #81 holding.
- UBS O'Connor first reported a position in GP-Act III Acquisition Corp in Q2 2025 and has held it in 3 quarters since.
- UBS O'Connor's GP-Act III Acquisition Corp position peaked at $3.71M in Q3 2025.
- 52 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q4 2025.
Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.